[ad_1] Merck & Co.has struck a deal to buy clinical-stage immunotherapy company Harpoon Therapeutics for about $680 million. Merck on Monday said it will pay $23 a share in cash…
Tag: Healthcare/Life Sciences
Johnson & Johnson to Acquire Cancer-Treatment Developer Amrbx for $2B
[ad_1] Johnson & Johnson will acquire cancer-treatment developer Ambrx Biopharma in a $2 billion cash deal. The pharmaceutical giant said Monday that the deal to acquire all shares of Ambrx…
CVS Names Cowhey Permanent Finance Chief as Guertin Departs
[ad_1] CVS Health on Friday said Shawn Guertin, its top finance executive who has been on a leave of absence since October due to family health reasons, won’t return to…
Nation’s Biggest Hospital Landlord Suffers New Losses
[ad_1] Medical Properties Trust, the country’s largest hospital landlord, said it would record about $350 million of write-downs related to its largest tenant, which had fallen behind on its rent,…
Ecstasy-for-Medicine Advocate Raises $100 Million
[ad_1] The Multidisciplinary Association for Psychedelic Studies, a nonprofit leader in the pharmaceutical psychedelics industry, has raised more than $100 million in a Series A private stock sale. MAPS needed…
DocGo CEO Defends Performance on New York City Migrant-Care Contract
[ad_1] DocGo Chief Executive Lee Bienstock is standing by the mobile-healthcare company’s performance under a controversial migrant-care contract awarded by New York City. In an interview, the former Google executive,…
You Can Now Get Weight-Loss Drugs Right From Eli Lilly
[ad_1] Eli Lilly started a new online service offering telehealth prescriptions and direct home delivery of its new anti-obesity drug Zepbound, an unusual move into the drug supply chain by…